Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Anzatax 300 mg/50 mL injection, 50 mL vial |
has TP |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 150 mg/25 mL injection, 25 mL vial |
Is a |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 150 mg/25 mL injection, 25 mL vial |
has TP |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 100 mg/16.7 mL injection, 16.7 mL vial |
Is a |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 100 mg/16.7 mL injection, 16.7 mL vial |
has TP |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 300 mg/50 mL injection, 50 mL vial |
Is a |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 300 mg/50 mL injection, 50 mL vial |
has TP |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 30 mg/5 mL injection, 5 mL vial |
Is a |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 30 mg/5 mL injection, 5 mL vial |
has TP |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax (paclitaxel 150 mg / 25 mL) injection, 1 x 25 mL vial (containered trade product pack) |
has TP |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 100 mg/16.7 mL injection, 16.7 mL vial |
has TP |
True |
Anzatax |
Inferred relationship |
Some |
|
Anzatax 30 mg/5 mL injection, 5 mL vial |
has TP |
True |
Anzatax |
Inferred relationship |
Some |
|